Investors Face Deadline in Hims & Hers Health Securities Fraud Case

The litigation centers on allegations that the company issued materially misleading statements regarding its business operations and regulatory standing. According to the complaint, Hims & Hers Health failed to disclose that it shared sensitive consumer health data with third-party advertising platforms and allegedly billed customers for prescriptions before they had consulted with medical providers.

These omissions reportedly exposed the company to significant regulatory scrutiny and potential financial penalties. Plaintiffs argue that these undisclosed practices rendered the company’s public declarations about its prospects and operations factually inaccurate. Investors seeking to participate in the action or obtain further information regarding their legal rights may contact the Law Offices of Frank R. Cruz via email or by calling 310-914-5007.